The genetic etiology of tourette syndrome: Large-scale collaborative efforts on the precipice of discovery

Frontiers in Neuroscience

Volumn 10, Issue AUG, 2016, Pages

  Georgitsi, Marianthi ^a,b   Willsey, A Jeremy ^c   Mathews, Carol A ^d   State, Matthew ^c   Scharf, Jeremiah M ^e   Paschou, Peristera ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Collaborative studies; Gene environment interactions; Genetics of complex disorders; Gilles de la Tourette syndrome; GWAS (genomewide association study); Neurodevelopmental disorders; Next generation sequencing

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; EXOME; FAMILY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOME; GENOTYPE ENVIRONMENT INTERACTION; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMMUNE RESPONSE; INFECTION; NONHUMAN; PATHOPHYSIOLOGY; SEQUENCE ANALYSIS;

EID: 84988395787     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2016.00351     Document Type: Article

References (79)

1. Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., et al. (2005). Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320. doi: 10.1126/science.1116502.
2. Adamczyk, A., Gause, C. D., Sattler, R., Vidensky, S., Rothstein, J. D., Singer, H., et al. (2011). Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome. Psychiatr. Genet. 21, 90-97. doi: 10.1097/YPG.0b013e328341a307.
3. Barr, C. L., Wigg, K. G., Pakstis, A. J., Kurlan, R., Pauls, D., Kidd, K. K., et al. (1999). Genome scan for linkage to Gilles de la Tourette syndrome. Am. J. Med. Genet. 88, 437-445. doi: 10.1002/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E.
4. Bertelsen, B., Melchior, L., Jensen, L. R., Groth, C., Nazaryan, L., Debes, N. M., et al. (2015). A t(3;9)(q25.1;q34.3) translocation leading to OLFM1 fusion transcripts in Gilles de la Tourette syndrome, OCD and ADHD. Psychiatry Res. 225, 268-275. doi: 10.1016/j.psychres.2014.12.028.
5. Boghosian-Sell, L., Comings, D. E., and Overhauser, J. (1996). Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. Am. J. Hum. Genet. 59, 999-1005.
6. Castellan Baldan, L., Williams, K. A., Gallezot, J.-D., Pogorelov, V., Rapanelli, M., Crowley, M., et al. (2014). Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 81, 77-90. doi: 10.1016/j.neuron.2013.10.052.
7. Chou, I.-C., Wan, L., Liu, S.-C., Tsai, C.-H., and Tsai, F.-J. (2007). Association of the Slit and Trk-like 1 gene in Taiwanese patients with Tourette syndrome. Pediatr. Neurol. 37, 404-406. doi: 10.1016/j.pediatrneurol.2007.06.017.
8. Church, A. J., Cardoso, F., Dale, R. C., Lees, A. J., Thompson, E. J., Giovannoni, G., et al. (2002). Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 59, 227-231. doi: 10.1212/WNL.59.2.227.
9. Comings, D. E., Comings, B. G., Muhleman, D., Dietz, G., Shahbahrami, B., Tast, D., et al. (1991). The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266, 1793-1800. doi: 10.1001/jama.1991.03470130073032.
10. Comings, D. E., Wu, S., Chiu, C., Ring, R. H., Gade, R., Ahn, C., et al. (1996). Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2, D beta H, and DAT1. Am. J. Med. Genet. 67, 264-288. doi: 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N.
11. Cruz, C., Camarena, B., King, N., Páez, F., Sidenberg, D., de la Fuente, J. R., et al. (1997). Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci. Lett. 231, 1-4.
12. Darrow, S. M., Illmann, C., Gauvin, C., Osiecki, L., Egan, C. A., Greenberg, E., et al. (2015). Web-based phenotyping for Tourette Syndrome: reliability of common co-morbid diagnoses. Psychiatry Res. 228, 816-825. doi: 10.1016/j.psychres.2015.05.017.
13. Dehning, S., Müller, N., Matz, J., Bender, A., Kerle, I., Benninghoff, J., et al. (2010). A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome. Psychiatr. Genet. 20, 35-38. doi: 10.1097/YPG.0b013e32833511ce.
14. Deng, H., Gao, K., and Jankovic, J. (2012). The genetics of Tourette syndrome. Nat. Rev. Neurol. 8, 203-213. doi: 10.1038/nrneurol.2012.26.
15. Deng, H., Le, W. D., Xie, W. J., and Jankovic, J. (2006). Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol. Scand. 114, 400-402. doi: 10.1111/j.1600-0404.2006.00706.x.
16. Díaz-Anzaldúa, A., Joober, R., Rivière, J.-B., Dion, Y., Lespérance, P., Richer, F., et al. (2004). Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol. Psychiatry 9, 272-277. doi: 10.1038/sj.mp.4001411.
17. Dietrich, A., Fernandez, T. V., King, R. A., State, M. W., Tischfield, J. A., Hoekstra, P. J., et al. (2014). The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods. Eur. Child Adolesc. Psychiatry 24, 141-151. doi: 10.1007/s00787-014-0543-x.
18. Egan, C. A., Marakovitz, S. E., O'Rourke, J. A., Osiecki, L., Illmann, C., Barton, L., et al. (2012). Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 987-996. doi: 10.1002/ajmg.b.32107.
19. Elia, J., Gai, X., Xie, H. M., Perin, J. C., Geiger, E., Glessner, J. T., et al. (2010). Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 15, 637-646. doi: 10.1038/mp.2009.57.
20. Ercan-Sencicek, A. G., Stillman, A. A., Ghosh, A. K., Bilguvar, K., O'Roak, B. J., Mason, C. E., et al. (2010). L-histidine decarboxylase and Tourette's syndrome. N. Engl. J. Med. 362, 1901-1908. doi: 10.1056/NEJMoa0907006.
21. Fernandez, T. V., Sanders, S. J., Yurkiewicz, I. R., Ercan-Sencicek, A. G., Kim, Y.-S. S., Fishman, D. O., et al. (2012). Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol. Psychiatry 71, 392-402. doi: 10.1016/j.biopsych.2011.09.034.
22. Gade, R., Muhleman, D., Blake, H., MacMurray, J., Johnson, P., Verde, R., et al. (1998). Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry 3, 50-60.
23. Girirajan, S., Brkanac, Z., Coe, B. P., Baker, C., Vives, L., Vu, T. H., et al. (2011). Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 7:e1002334. doi: 10.1371/journal.pgen.1002334.
24. Grice, D. E., Leckman, J. F., Pauls, D. L., Kurlan, R., Kidd, K. K., Pakstis, A. J., et al. (1996). Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am. J. Hum. Genet. 59, 644-652.
25. Hartmann, A., and Worbe, Y. (2013). Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci. Biobehav. Rev. 37, 1157-1161. doi: 10.1016/j.neubiorev.2012.10.014.
26. Hasstedt, S. J., Leppert, M., Filloux, F., van de Wetering, B. J., and McMahon, W. M. (1995). Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am. J. Hum. Genet. 57, 682-689.
27. Herzberg, I., Valencia-Duarte, A. V., Kay, V. A., White, D. J., Müller, H., Rivas, I. C., et al. (2010). Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate. Psychiatr. Genet. 20, 179-183. doi: 10.1097/YPG.0b013e32833a215a.
28. Hirschtritt, M. E., Lee, P. C., Pauls, D. L., Dion, Y., Grados, M. A., Illmann, C., et al. (2015). Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 72, 325-333. doi: 10.1001/jamapsychiatry.2014.2650.
29. Hoekstra, P. J., Dietrich, A., Edwards, M. J., Elamin, I., and Martino, D. (2013). Environmental factors in Tourette syndrome. Neurosci. Biobehav. Rev. 37, 1040-1049. doi: 10.1016/j.neubiorev.2012.10.010.
30. Kalanithi, P. S. A., Zheng, W., Kataoka, Y., DiFiglia, M., Grantz, H., Saper, C. B., et al. (2005). Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 13307-13312. doi: 10.1073/pnas.0502624102.
31. Karagiannidis, I., Dehning, S., Sandor, P., Tarnok, Z., Rizzo, R., Wolanczyk, T., et al. (2013). Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J. Med. Genet. 50, 760-764. doi: 10.1136/jmedgenet-2013-101637.
32. Karagiannidis, I., Rizzo, R., Tarnok, Z., Wolanczyk, T., Hebebrand, J., Nöthen, M. M., et al. (2012). Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families. Mol. Psychiatry 17, 665-668. doi: 10.1038/mp.2011.151.
33. Katuwawela, I. (2012). Good response to clonidine in tourette syndrome associated with chromosomal translocation involving the IMMP2L gene. J. Neuropsychiatry Clin. Neurosci. 24:E17. doi: 10.1176/appi.neuropsych.11010032.
34. Kroisel, P. M., Petek, E., Emberger, W., Windpassinger, C., Wladika, W., Wagner, K., et al. (2001). Candidate region for Gilles de la Tourette syndrome at 7q31. Am. J. Med. Genet. 101, 259-261. doi: 10.1002/1096-8628(20010701)101:3<259::AID-AJMG1374>3.0.CO;2-#.
35. Kurlan, R., Eapen, V., Stern, J., McDermott, M. P., and Robertson, M. M. (1994). Bilineal transmission in Tourette's syndrome families. Neurology 44, 2336-2342.
36. Lam, S., Shen, Y., Nguyen, T., Messier, T. L., Brann, M., Comings, D., et al. (1996). A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient. Biochem. Biophys. Res. Commun. 219, 853-858.
37. Lawson-Yuen, A., Saldivar, J.-S., Sommer, S., and Picker, J. (2008). Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur. J. Hum. Genet. 16, 614-618. doi: 10.1038/sj.ejhg.5202006.
38. Lee, C. C., Chou, I.-C., Tsai, C.-H., Wang, T.-R., Li, T.-C., Tsai, F.-J., et al. (2005). Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr. Neurol. 33, 272-276. doi: 10.1016/j.pediatrneurol.2005.05.005.
39. Lei, J., Deng, X., Zhang, J., Su, L., Xu, H., Liang, H., et al. (2012). Mutation screening of the HDC gene in Chinese Han patients with Tourette syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 72-76. doi: 10.1002/ajmg.b.32003.
40. Maestrini, E., Pagnamenta, A. T., Lamb, J. A., Bacchelli, E., Sykes, N. H., Sousa, I., et al. (2010). High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol. Psychiatry 15, 954-968. doi: 10.1038/mp.2009.34.
41. Martino, D., Dale, R. C., Gilbert, D. L., Giovannoni, G., and Leckman, J. F. (2009). Immunopathogenic mechanisms in tourette syndrome: a critical review. Mov. Disord. 24, 1267-1279. doi: 10.1002/mds.22504.
42. Mathews, C. A., and Grados, M. A. (2011). Familiality of Tourette syndrome, obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample. J. Am. Acad. Child Adolesc. Psychiatry 50, 46-54. doi: 10.1016/j.jaac.2010.10.004.
43. Mathews, C. A., Scharf, J. M., Miller, L. L., Macdonald-Wallis, C., Lawlor, D. A., and Ben-Shlomo, Y. (2014). Association between pre-and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort. Br. J. Psychiatry 204, 40-45. doi: 10.1192/bjp.bp.112.125468.
44. McGrath, L. M., Yu, D., Marshall, C., Davis, L. K., Thiruvahindrapuram, B., Li, B., et al. (2014). Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J. Am. Acad. Child Adolesc. Psychiatry 53, 910-919. doi: 10.1016/j.jaac.2014.04.022.
45. Miranda, D. M., Wigg, K., Kabia, E. M., Feng, Y., Sandor, P., Barr, C. L., et al. (2009). Association of SLITRK1 to Gilles de la Tourette Syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 483-486. doi: 10.1002/ajmg.b.30840.
46. Mössner, R., Müller-Vahl, K. R., Döring, N., and Stuhrmann, M. (2007). Role of the novel tryptophan hydroxylase-2 gene in Tourette syndrome. Mol. Psychiatry 12, 617-619. doi: 10.1038/sj.mp.4002004.
47. Moya, P. R., Dodman, N. H., Timpano, K. R., Rubenstein, L. M., Rana, Z., Fried, R. L., et al. (2013). Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes. Eur. J. Hum. Genet. 21, 850-854. doi: 10.1038/ejhg.2012.245.
48. Murphy, T. K., Kurlan, R., and Leckman, J. (2010). The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J. Child Adolesc. Psychopharmacol. 20, 317-331. doi: 10.1089/cap.2010.0043.
49. Nag, A., Bochukova, E. G., Kremeyer, B., Campbell, D. D., Muller, H., Valencia-Duarte, A. V., et al. (2013). CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. PLoS ONE 8:e59061. doi: 10.1371/journal.pone.0059061.
50. O'Rourke, J., Scharf, J., Yu, D., and Pauls, D. (2009). The genetics of Tourette syndrome: a review. J. Psychosom. Res. 67, 533-545. doi: 10.1016/j.jpsychores.2009.06.006.
51. Pagnamenta, A. T., Bacchelli, E., de Jonge, M. V., Mirza, G., Scerri, T. S., Minopoli, F., et al. (2010). Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol. Psychiatry 68, 320-328. doi: 10.1016/j.biopsych.2010.02.002.
52. Pakstis, A. J., Heutink, P., Pauls, D. L., Kurlan, R., van de Wetering, B. J., Leckman, J. F., et al. (1991). Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome. Am. J. Hum. Genet. 48, 281-294.
53. Paschou, P. (2013). The genetic basis of gilles de la Tourette syndrome. Neurosci. Biobehav. Rev. 37, 1026-1039. doi: 10.1016/j.neubiorev.2013.01.016.
54. Paschou, P., Yu, D., Gerber, G., Evans, P., Tsetsos, F., Davis, L. K., et al. (2014). Genetic association signal near NTN4 in Tourette syndrome. Ann. Neurol. 76, 310-315. doi: 10.1002/ana.24215.
55. Patel, C., Cooper-Charles, L., McMullan, D. J., Walker, J. M., Davison, V., Morton, J., et al. (2011). Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome. Eur. J. Hum. Genet. 19, 634-639. doi: 10.1038/ejhg.2010.238.
56. Pauls, D. L., Fernandez, T. V., Mathews, C., State, M. W., and Scharf, J. M. (2014). The inheritance of Tourette disorder: a review. J. Obsessive Compuls. Relat. Disord. 3, 380-385. doi: 10.1016/j.jocrd.2014.06.003.
57. Petek, E., Schwarzbraun, T., Noor, A., Patel, M., Nakabayashi, K., Choufani, S., et al. (2007). Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol. Genet. Genomics 277, 71-81. doi: 10.1007/s00438-006-0173-1.
58. Petek, E., Windpassinger, C., Vincent, J. B., Cheung, J., Boright, A. P., Scherer, S. W., et al. (2001). Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am. J. Hum. Genet. 68, 848-858. doi: 10.1086/319523.
59. Peterson, B. S., Thomas, P., Kane, M. J., Scahill, L., Zhang, H., Bronen, R., et al. (2003). Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch. Gen. Psychiatry 60, 415-424. doi: 10.1001/archpsyc.60.4.415.
60. Poot, M., Beyer, V., Schwaab, I., Damatova, N., Van'T Slot, R., Prothero, J., et al. (2010). Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11, 81-89. doi: 10.1007/s10048-009-0205-1.
61. Rapanelli, M., Frick, L. R., Pogorelov, V., Ota, K. T., Abbasi, E., Ohtsu, H., et al. (2014). Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome. Eur. Neuropsychopharmacol. 24, 1896-1906. doi: 10.1016/j.euroneuro.2014.10.007.
62. Robertson, M. M. (2008). The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J. Psychosom. Res. 65, 461-472. doi: 10.1016/j.jpsychores.2008.03.006.
63. Sanders, S. J., He, X., Willsey, A. J., Ercan-Sencicek, A. G., Samocha, K. E., Cicek, A. E., et al. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215-1233. doi: 10.1016/j.neuron.2015.09.016.
64. Scharf, J. M., Miller, L. L., Gauvin, C. A., Alabiso, J., and Mathews, C. A. (2015). Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov. Disord. 30, 221-228. doi: 10.1002/mds.26089.
65. Scharf, J. M., Moorjani, P., Fagerness, J., Platko, J. V., Illmann, C., Galloway, B., et al. (2008). Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 70, 1495-1496. doi: 10.1212/01.wnl.0000296833.25484.bb.
66. Scharf, J. M., Yu, D., Mathews, C. A., Neale, B. M., Stewart, S. E., Fagerness, J. A., et al. (2013). Genome-wide association study of Tourette's syndrome. Mol. Psychiatry 18, 721-728. doi: 10.1038/mp.2012.69.
67. State, M. W. (2011). The genetics of Tourette disorder. Curr. Opin. Genet. Dev. 21, 302-309. doi: 10.1016/j.gde.2011.01.007.
68. Sun, N., Tischfield, J. A., King, R. A., and Heiman, G. A. (2016). Functional evaluations of genes disrupted in patients with Tourette's disorder. Front. psychiatry 7:11. doi: 10.3389/fpsyt.2016.00011.
69. Sundaram, S. K., Huq, A. M., Wilson, B. J., and Chugani, H. T. (2010). Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 74, 1583-1590. doi: 10.1212/WNL.0b013e3181e0f147.
70. Swain, J. E., Scahill, L., Lombroso, P. L., King, R. A., and Leckman, J. F. (2007). Tourette syndrome and tic disorders: a decade of progress. J. Am. Acad. Child Adolesc. Psychiatry 46, 947-968. doi: 10.1097/chi.0b013e318068fbcc.
71. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., et al. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 155, 264-271. doi: 10.1176/ajp.155.2.264.
72. Tarnok, Z., Ronai, Z., Gervai, J., Kereszturi, E., Gadoros, J., Sasvari-Szekely, M., et al. (2007). Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 144, 900-905. doi: 10.1002/ajmg.b.30517.
73. TSAICG (2007). Genome scan for tourette disorder in affected-sibling-pair and multigenerational families. Am. J. Hum. Genet. 80, 265-272. doi: 10.1086/511052.
74. Verkerk, A., Mathews, C. A., Joosse, M., Eussen, B. B. H. J., Heutink, P., Oostra, B. B. A., et al. (2003). CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive comulsive disorder. Genomics 82, 1-9. doi: 10.1016/S0888-7543(03)00097-1.
75. Willsey, A. J., Sanders, S. J., Li, M., Dong, S., Tebbenkamp, A. T., Muhle, R. A., et al. (2013). Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155, 997-1007. doi: 10.1016/j.cell.2013.10.020.
76. Yoon, D. Y., Gause, C. D., Leckman, J. F., and Singer, H. S. (2007). Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis. J. Neurol. Sci. 255, 50-56. doi: 10.1016/j.jns.2007.01.069.
77. Yu, D., Mathews, C. A., Scharf, J. M., Neale, B. M., Davis, L. K., Gamazon, E. R., et al. (2015). Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am. J. Psychiatry 172, 82-93. doi: 10.1176/appi.ajp.2014.13101306.
78. Zilhão, N. R., Padmanabhuni, S. S., Pagliaroli, L., Barta, C., Smit, D. J. A., Cath, D., et al. (2015). Epigenome-wide association study of tic disorders. Twin Res. Hum. Genet. 18, 699-709. doi: 10.1017/thg.2015.72.
79. Zimprich, A., Hatala, K., Riederer, F., Stogmann, E., Aschauer, H. N., Stamenkovic, M., et al. (2008). Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder. Psychiatr. Genet. 18, 308-309. doi: 10.1097/YPG.0b013e3283060f6f.